Doxercalciferol in Recurrent Pediatric Solid Tumors
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Doxercalciferol in Recurrent Pediatric Solid Tumors is a clinical trial[1].
Key Facts
- Doxercalciferol in Recurrent Pediatric Solid Tumors is in the country of United States[2].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's instance of is recorded as clinical trial[3].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's start time is recorded as +2007-08-31T00:00:00Z[4].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's end time is recorded as +2010-09-30T00:00:00Z[5].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's sponsor is recorded as The University of Texas MD Anderson Cancer Center[6].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's main subject is recorded as childhood cancer of liver[7].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's main subject is recorded as rickets[8].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's number of participants is recorded as {'unit': '1', 'amount': '+1'}[9].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's title is recorded as A Phase I Study of Doxercalciferol in Recurrent Pediatric Solid Tumors[10].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+2'}[11].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's ClinicalTrials.gov ID is recorded as NCT00511017[12].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+26'}[13].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's research intervention is recorded as doxercalciferol[14].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's research intervention is recorded as Ergocalciferols[15].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's clinical trial phase is recorded as phase I clinical trial[16].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's research site is recorded as University of Texas at Houston Police Department[17].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's research subject recruitment status is recorded as terminated[18].
- Doxercalciferol in Recurrent Pediatric Solid Tumors's study type is recorded as interventional study[19].